Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer. Despite advancements in the treatment strategies of HCC, there is an urgent requirement to identify and develop novel therapeutic drugs that do not lead to resistance. These novel agents should have the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshehri, Mohammed A., Alshehri, Moath M., Albalawi, Naif N., Al-Ghamdi, Moshari A., Al-Gayyar, Mohammed M.H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798035/
https://www.ncbi.nlm.nih.gov/pubmed/33552290
http://dx.doi.org/10.3892/ol.2021.12434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798035/
https://www.ncbi.nlm.nih.gov/pubmed/33552290
http://dx.doi.org/10.3892/ol.2021.12434

Ejemplares similares